Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02522390
Other study ID # P9616
Secondary ID
Status Active, not recruiting
Phase N/A
First received March 23, 2015
Last updated April 24, 2017
Start date January 2015
Est. completion date January 2025

Study information

Verified date April 2017
Source TNO
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The primary objective of the planned Nutrition Research Cohort (NRC) n250 study is to develop and evaluate the open access Nutrition Researcher Cohort for gathering personal health data from nutrition researchers, including analytical methods, standards and operation procedures, data infrastructure, ethical and privacy aspects, and governance.

Besides, the study aims to exploit and analyse data on food, nutrient and bioactive compound intake and exposure, biomarkers for food, health and/or disease and health and/or disease related measurements to study the relation between nutrition, health and development of disease (on individual level).

In addition, data will be used to develop applications that visualise personal health risks based for example on (validated) recommendations and applications that predict individual health risks.

The study is designed as an open, one-group, exploratory cohort study. The total NRC cohort will be composed of about 250 life sciences employees and students from different, predominantly European, countries. This allows optimal involvement of participants in shaping all aspects of the cohort and the ownership of data. We aim to recruit about in total 20 male and female scientists per participating country.


Description:

The NRC n250 study is an open, one-group, open-ended cohort study, which will include participants from 10 different countries. The study will be coordinated by national contact points from each of the participating countries.

The NRC cohort study will start early 2015 and continue developing from that moment on. Recruitment will start immediately after approval of the study protocol in the country where it has been submitted. The Participant Information Form, which contains the complete research protocol as developed by the consortium partners, is available online via the NRC website. This way, potential participants can make an informed decision on whether or not they want to participate.

The NRC n250 study will provide a dataset from 250 individuals, including food intake, microbiome composition, oral glucose tolerance tests, a series of plasma (bio)chemistry outcomes, plasma and urine metabolome and DNA damage, together with anthropometrics and life style questionnaires.

Since the aim is to build up a powerful open access cohort, there is no end-date defined for this study. The collected data will be used for various analyses on food intake, biomarkers for food intake and/or health and/or disease, and health/disease related measurements.

The research questions that will be answered with this cohort are largely not known yet, since it is not known which data will become available. A NRC Scientific committee is established to judge whether or not the data in the cohort may be used for answering the proposed research questions. This Scientific committee consists of the principal investigators of the individual participating countries.

The Scientific committee is the entity that views all proposals (new studies, research questions) and decides whether or not it is in line with aim of NRC as well as ethics as well as scientifically robust. Approval for proposals can be obtained by positive response from a majority of the members (quality and ethics of proposals).

Institutions/companies that obtain data for a specific proposal, are only allowed to use the data for that specific purpose.

The NRC cohort also aims to serve as a platform to validate specific questionnaires (including food intake) or additional measurements (that are within scope of the NRC objectives). For offering an additional measurement or questionnaire to participants for health parameters that are already included in the protocols, also a request for approval should be filed to the scientific committee. The scientific committee will then decide (based on a positive response of the majority of the committee) if this measurement or questionnaire may be added. A request for data analysis with these new measures or questionnaires, other than validation purposes, has to be filed separately. If a request for approval is granted, participants still have the opportunity to opt out their data for use for this purpose.

For research questions that require additional measurements for health parameters that are not yet included in the protocol, amendments will be submitted to the Dutch Medical Research and Ethics Committee (MREC).


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 192
Est. completion date January 2025
Est. primary completion date January 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Employees or students that are active in the field of nutrition and/or biology and/or health (e.g. epidemiologists, dieticians, nutrition students and researchers) that have a basic knowledge of nutrition and/or human biology and are thus able to form a scientific judgement on his/her own health data;

- good understanding of the English written language, since all communication is handled in English.

Exclusion Criteria:

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Research activities
Measurements are primarily based on "do-it-yourself" non-invasive or minimally invasive methods. Participants upload collected data to the Personal Health Portal. The measurements are divided into required and optional measurements. The required measurements mainly include routine methodology (e.g. weight, blood pressure, blood glucose); the latter also include methods under development that will be fine-tuned along the project. Which additional measures will be offered to participants is dependent on if funding or in-kind sponsoring is available. Participants will receive measurement kits for these analyses at-home and will be responsible for collection, labeling and shipment of samples themselves. After analysis the resulting data are uploaded to the user accounts.

Locations

Country Name City State
Austria Medizinische Universität Graz Graz
Belgium University of Leuven (KU Leuven) Leuven
Czechia Charles University Prague Prague
Denmark University of Copenhagen Copenhagen
Finland University of Eastern Finland Kuopio
France INRA - L'Institut Nationel de la Recherche Agronomique Clermont
Ireland University College Dublin Dublin
Italy CRA-NUT - Centro di Ricerca per gli Alimenti e la Nutrizione Rome
Netherlands TNO Zeist Gelderland
Spain University of Barcelona Barcelona
Switzerland Agroscope, Institute for Food Sciences Berne
United Kingdom Newcastle University Newcastle

Sponsors (21)

Lead Sponsor Collaborator
TNO Agroscope Liebefeld-Posieux Research Station ALP, Charles University, Czech Republic, CRA NUT - Centro di Ricerca per gli Alimenti e la Nutrizione, CSIRO Animal, Food and Health Sciences, Humboldt-Universität zu Berlin, Lund University, Newcastle University, NIHS, NuGo, SwissAnalysis AG, Technical University Munchen, Tufts University, Universitaire Ziekenhuizen Leuven, University College Dublin, University of Barcelona, University of Copenhagen, University of Eastern Finland, University of Graz, University of Oslo, VITAS Analytical Services

Countries where clinical trial is conducted

Austria,  Belgium,  Czechia,  Denmark,  Finland,  France,  Ireland,  Italy,  Netherlands,  Spain,  Switzerland,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Other compliance with the study protocol compliance will be determined for each of the included measurements and compared between participating countries after one year (june 2016)
Other user experiences with participating in the cohort as measured via a questionnaire after one year (june 2016)
Primary Body height measured with do-it-yourself device in at-home setting Baseline (week 1)
Primary Body weight measured with do-it-yourself device in at-home setting Each week during entire cohort (five years in total)
Primary Single Nucleotide Polymorphism (SNP) profile No specific time of measurement has to be specified as genetic profile is not subject to change Once during the cohort at baseline (a timepoint chosen by the participant in the first three months of the cohort)
Primary Waist-to-hip ratio measured with waist circumference and hip circumference; measured with centimeter in at-home setting Monthly during entire cohort (Month 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 for each year of the five year cohort)
Primary Blood pressure Diastolic and systolic blood pressure; measured with do-it-yourself device in at-home setting Monthly during entire cohort (Month 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 for each year of the five year cohort)
Primary Resting heart rate measured after sitting still for at least 5 minutes; measured with do-it-yourself device in at-home setting Monthly during entire cohort (Month 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 for each year of the five year cohort)
Primary fasting blood glucose measured after 8h fasting (only drinking water is allowed); measured with do-it-yourself device in at-home setting Monthly during entire cohort (Month 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 for each year of the five year cohort)
Primary Blood cholesterol HDL, LDL, total cholesterol, triglycerides; measured with do-it-yourself device in at-home setting quarterly during entire cohort (Month 3, M6, M9, M12 for each year of the five year cohort)
Primary Food intake registration of food intake during two weekdays and one weekend day via an online application (e.g. FatSecret) quarterly during entire cohort (Month 3, M6, M9, M12 for each year of the five year cohort)
Primary Physical activity tracker Registration of physical activity with a physical activity tracker (e.g. FitBit) for at least one week continuously quarterly during entire cohort (Month 3, M6, M9, M12 for each year of the five year cohort)
Secondary biomarker profile biomarkers for food intake (vitamins, fatty acids) and other blood biomarkers (cortisol, C Reactive protein (CRP), thyroid stimulating hormone (TSH), etc.) once, at baseline (at a timepoint chosen by the participant in the first three months of the cohort); this measure will be repeated only if funding for analysis becomes available
Secondary do-it-yourself oral glucose tolerance test insulin, glucose, c-peptide, HbA1c; including response profile after oral glucose tolerance test once, at baseline (at a timepoint chosen by the participant in the first three months of the cohort); this measure will be repeated only if funding for analysis becomes available
Secondary metabolomics once, at baseline (at a timepoint chosen by the participant in the first three months of the cohort); this measure will be repeated only if funding for analysis becomes available
Secondary metagenome once, at baseline (at a timepoint chosen by the participant in the first three months of the cohort); this measure will be repeated only if funding for analysis becomes available
Secondary general health status via a questionnaire once per year during entire cohort (Month 12, M24, M36, M48, M60)
Secondary lifestyle (smoking, alcohol consumption, etc.) via a questionnaire once per year during entire cohort (Month 12, M24, M36, M48, M60)
Secondary general food intake via a food frequency questionnaire once per year during entire cohort (Month 12, M24, M36, M48, M60)
Secondary quality of sleep via a questionnaire once per year during entire cohort (Month 12, M24, M36, M48, M60)
Secondary stress questionnaire once per year during entire cohort (Month 12, M24, M36, M48, M60)
Secondary physical activity via a questionnaire once per year during entire cohort (Month 12, M24, M36, M48, M60)
Secondary wellness via a questionnaire once per year during entire cohort (Month 12, M24, M36, M48, M60)
Secondary cognition via a questionnaire once per year during entire cohort (Month 12, M24, M36, M48, M60)
Secondary quality of life via a questionnaire once per year during entire cohort (Month 12, M24, M36, M48, M60)
See also
  Status Clinical Trial Phase
Completed NCT03601715 - Analysis of Human Tissue Temperature After Application of Therapeutic Modalities. N/A
Completed NCT02145273 - Healthy Moms-Healthy Kids: Reducing Maternal Depression for Better Outcomes in Head Start Children N/A
Recruiting NCT01985152 - A Phase Ⅰa Study of Azilsartan Trimethylethanolamine in Healthy Volunteers Phase 1
Active, not recruiting NCT00970398 - Effect of an Infant Formula on Infant Growth, Health and Immune Functions N/A
Completed NCT00332137 - Effects of Tolterodine, a Non-Specific Muscarinic Antagonist, on Gastrointestinal Transit in Healthy Subjects Phase 2
Recruiting NCT06060379 - Giochiamo 626 - Gaming for Health and Safety in Workplaces N/A
Completed NCT04998266 - Evaluation of Physical Capacities Within the Company and Effect of a Personalized Versus Traditional Training Program on the Quality of Life of Sedentary Employees N/A
Completed NCT01214278 - Bioavailability of Different n-3 Fatty Acid Formulations Phase 4
Recruiting NCT06157346 - Characteristics of Intestinal Bacteria and Their Effects on Growth and Immune Function in Children at High Altitude
Completed NCT01057368 - The Effects of Well-being Interventions on Affect, Attention, Sleep, Social Stress and Pain Regulation N/A
Completed NCT01216605 - Oxytocin and Emotion Recognition Phase 4
Completed NCT02287441 - Feasibility Study to Increase Vegetable Consumption N/A
Recruiting NCT02132741 - Optical Coherence Tomography And NEphropathy: The OCTANE Study
Completed NCT01762553 - TEA for Families and Children: A Randomized Intervention Trial N/A
Completed NCT01123772 - Phase I Dose-Escalation Study to Evaluate Tolerability, Safety & PK of INO-8875 in Healthy Older-Adult Volunteers Phase 1
Completed NCT03527654 - SER Hispano Longitudinal Study
Completed NCT03414346 - Analysis of the Effects on Human Tissues After Application of Therapeutic Modalities. N/A
Completed NCT02116283 - Mobile Sensing of Smoking Behavior N/A
Completed NCT05104385 - Hacettepe University COVID-19 Vaccinated's Health Cohort- Students of Health Sciences
Completed NCT00962195 - The Effect of Purple Sweet Potato (PSP)-Juice on Liver Enzymes and Blood Pressure N/A